In the first installment of a two-part interview, Lynne Fruth, CEO of Fruth Pharmacy, tells this week’s Video Forum about the company’s role in securing passage of legislation to rein in PBM practices under West Virginia’s public employees insurance plan.
In the first installment of a two-part interview, Lynne Fruth, CEO of Fruth Pharmacy, tells this week’s Video Forum about the company’s role in securing passage of legislation to rein in PBM practices under West Virginia’s public employees insurance plan. She discusses the benefits that the changes will bring to patients, taxpayers and retail pharmacies.
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
The company expects consumer spending to grow at a healthy pace of 3.1% in 2025.
Glenmark's phytonadione injectable emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc.
The legislation seeks to address a long-standing issue that has significant implications for businesses and consumers alike.
Dr. Dickinson played a pivotal role in the growth and evolution of both CRN and the dietary supplement industry.
